Clinical value of heart type fatty acid binding protein (H-FABP) in acute pulmonary thromboembolism-Reference-Cited by-同舟云学术

Clinical value of heart type fatty acid binding protein (H-FABP) in acute pulmonary thromboembolism

Published:2022-05-30 Issue:3 Volume:5 Page:861-867
ISSN:2636-8579
Container-title:Journal of Health Sciences and Medicine
language:en
Short-container-title:J Health Sci Med / JHSM

Author:

ALTUĞ Tuba¹,ŞENTÜRK Ayşegül²,ALIŞIK Murat³,BİÇER Cemile

Affiliation:

1. Public Hospital, Department of Chest Diseases, Kayseri, Turkey

2. Ankara Ataturk Chest Disease and Chest Surgery Education and Research Hospital, Department of Chest Diseases, Ankara, Turkey

3. Bolu Abant İzzet Baysal University Department of Biochemistry, Bolu, Turkey

Abstract

Introduction: To investigate factors which could possibly be prognostic, to decide on thrombolytic therapy as soon as possible, and to determine the prognostic value of H-FABP, which is a new marker, in pulmonary thromboembolism. Material and Method: In our study, a patient group, consisting of 58 patients diagnosed with PTE and a control group of 30 healthy individuals were investigated. According to their risk of mortality, patients were analyzed in three groups: high, moderate and low. The moderate mortality risk groups were categorized into two groups according to PAP and patients with PAP≥45 mmHg were “Group 1” and PAP

Publisher

Journal of Health Sciences and Medicine

Subject

General Medicine

Reference24 articles.

1. Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest 2002; 122: 1440-56.

2. Nijkeuter M, Sohne M, Tick LW, et al. The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study. Chest 2007; 131: 517-23.

3. Duffett L, Castellucci L A, Forgie M A. Pulmonary embolism: update on management and controversies BMJ 2020; 370.

4. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41: 543-603.

5. Babaoglu E, Hasanoglu HC, Senturk A, et al. Importance of biomarkers in risk stratification of pulmonary thromboembolism patients. J Investig Med 2014; 62: 328-31.